CORRELATION OF UREMIC TOXINS AND INFLAMMATION MARKERS IN PATIENTS WITH CHRONIC RENAL FAILURE
https://doi.org/10.24884/1561-6274-2004-8-4-62-67
Abstract
THE AIM of the work was to study effects of substances of low and middle molecular mass (SLMMM), considered as uremic toxins, upon the indicators showing inflammation. PATIENTS AND METHODS. The investigated group included 30 patients with normal function of the kidneys, 77 patients with predialysis stage of chronic renal failure (CRF) and 54 patients with terminal CRF receiving substitution therapy with hemodialysis (HD). At the moment of examination the patients did not have symptoms of exacerbation of the main disease of the kidneys or coexisting diseases. The concentration of SLMMM was determined in patients with different stages of CGN and then a correlation analysis of interrelations between SLMMM and indices of inflammation (ESR, fibrinogen, CRP, IL6, TNFalpha, albumin, albumin binding power) was made. RESULTS. Positive correlative interrelations of SLMMM with ESR, fibrinogen, IL6 and negative with albumin and albumin binding power were obtained. When the SLMMM indices were elevated the indices of general inflammatory syndrome became worse: ESR, level of IL6 and fibrinogen became higher, while albumin and albumin binding power decreased. CONCLUSION. An analysis of the data obtained allows a supposition that uremia is a cause maintaining inflammation in patients with CGN and in future can result in the development of atherosclerosis, ischemic heart disease, complications to the cardiovascular system.
About the Authors
T. V. ZhdanovaRussian Federation
A. V. Nazarov
Russian Federation
V. A. Shalaev
Russian Federation
Ya. B. Beikin
Russian Federation
Yu. G. Lagereva
Russian Federation
A. Yu. Druzhinina
Russian Federation
S. V. Menshikov
Russian Federation
N. N. Kuznetsov
Russian Federation
G. A. Vershinina
Russian Federation
References
1. Brown JH, Hunt LP, Vites NP et al. Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994; 9(8):1136 – 1142
2. Levey AS, Beto JA , Coronado BE et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 1998 (32):853 – 833
3. Волгина ГВ. Клиническая эпидемиология кардиоваскулярных нарушений при хронической почечной недоста точности (Обзор литературы). Нефрология и диализ 2000; (12):25 –32
4. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10 (7):16061615
5. Cheung AK, Sarnak MJ, Yan G et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58 (1):353362
6. Титов ВН. Общность атеросклероза и воспаления: специфичность атеросклероза как воспалительного процесса (гипотеза). Клиническая лабораторная диагностика 2000 (4):3 – 10
7. Ridker PM, Glynn RJ, Hennekens CH. Creactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97(20):20072011
8. Ridker PM, Cushman M, Stampfer MJ et al. Plasma concentration of Creactive protein and risk of developing peripheral vascular disease. Circulation 1998;97(5):425428
9. Koenig W, Sund M, Frohlich M et al. Creactive protein, a sensitive marker of systemic inflammation, predicts future risk of coronary heart disease in initially healthy middleaged men. Results from the MONICAAugsburg cohort study 1984–92. Circulation 1999;99 (2):237242
10. Toss H, Lindahl B, Siegbahn A et al. Prognostic influence of increased Fibrinogen and Creactive levels in unstabile coronary artery disease. Circulation 1997;96 (12):42044210
11. Heinrich J, Balleisen L, Schulte H et al. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men [published erratum appears in Arterioscler Thromb 1994 Aug;14(8):1392] Arteriosclerosis Thrombosis 1994; 14 (1):5459
12. Kaysen GA. Malnutrition and the acutephase reaction in dialysis patients – how to measure and how to distinguish. Nehprol Dial Transplant 2000;15(10):15211524
13. Stenvinkel P, Heimbьrger O, Lindholm B et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nehprol Dial Transplant 2000;15(7):953960
14. Stenvinkel P, Heimbьrger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 5(5):1899–1911
15. Гаврилов ВБ, Бидула ММ, Фурманчук ДА. Снижение эффективной концентрации альбумина как индикатор дисбаланса между накоплением и связыванием токсинов в плазме крови при эндогенной интоксикации. В: Грызунов ЮА и Добрецов ГЕ, ред. Альбумин сыворотки крови в клинической медицине. Ириус, М., 1998;132139
Review
For citations:
Zhdanova T.V., Nazarov A.V., Shalaev V.A., Beikin Ya.B., Lagereva Yu.G., Druzhinina A.Yu., Menshikov S.V., Kuznetsov N.N., Vershinina G.A. CORRELATION OF UREMIC TOXINS AND INFLAMMATION MARKERS IN PATIENTS WITH CHRONIC RENAL FAILURE. Nephrology (Saint-Petersburg). 2004;8(4):62-67. (In Russ.) https://doi.org/10.24884/1561-6274-2004-8-4-62-67